| The MET proto-oncogene is not a major target for the gain of chromosome 7 in testicular germ-cell tumors of adolescents. | testicular, |
| Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. | kidney, |
| Met proto-oncogene and insulin-like growth factor binding protein 3 have roles in metastasis of well-differentiated pancreatic endocrine neoplasms | pancreatic,neoplasm, |
| Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis. | lung, |
| Overexpression of wild-type MET leads to the development of nonprogressive neoplasms. The lesions progressed to mammary adenocarcinoma when a second protooncogene, MYC, was overexpressed, indicating that MET and MYC cooperate in mammary tumorigenesis. | neoplasm, |
| Targeting the activated, human MET oncogene to adult mouse liver caused slowly progressing hepatocarcinogenesis | liver, |
| Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. | colorectal, |
| [Effect of proto-oncogene protein c-met ribozyme transfection on biological behavior of gastric carcinoma cells]. | gastric, |
| Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells. | breast, |
| Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. | colorectal, |
| Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma. | esophageal, |
| Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. | colorectal, |
| MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. | lung, |
| Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. | colorectal, |
| The abnormal expression of c-met and PCNA protein was related with the oncogenesis of gastric carcinoma. | gastric, |
| Lack of oncogenic mutations in the c-Met catalytic tyrosine kinase domain in acral lentiginous melanoma | skin, |
| Lack of oncogenic mutations in the c-Met catalytic tyrosine kinase domain in acral lentiginous melanoma. | skin, |
| Stromal changes associated with breast cancer can control proto-oncogene function. | breast, |
| study found four gastric cancer cell lines harbored amplification of c-met locus, and among them, Hs746T had a putative oncogenic mutation with amplification | gastric, |
| Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer | bladder, |